Crown Electrokinetics Corp. CRKN shares are trading higher by 6.9% to $0.09 during Wednesday's session after the company announced that its request for continued listing on the Nasdaq was approved. A hearing regarding the matter took place on May 7.
On June 11, the company was notified that the Panel granted its request for continued listing on Nasdaq, contingent upon meeting all applicable criteria by July 23.
The company says it is working to meet these conditions, but there is no guarantee it will succeed.
Is CRKN A Good Stock To Buy?
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Crown ElectroKinetics‘s page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. Crown ElectroKinetics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 14.21%, you'll need to buy a share of Apollo Comml Real Est by the Jun. 28, 2024. Once done, you can expect to receive a nominal payout of $0.35 on Jul. 15, 2024.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Crown ElectroKinetics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from Benzinga Pro, CRKN has a 52-week high of $11.38 and a 52-week low of $0.04.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.